YMAB: Y-mAbs Therapeutics Inc
YMAB exchange rate has changed by 0.23% for today. During the day, the instrument was traded at a low of 8.59 and at a high of 8.61.
Follow Y-mAbs Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
YMAB News
- Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?
- Y mAbs Therapeutics earnings beat by $0.19, revenue topped estimates
- Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates
- Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
- Keros Therapeutics, Inc. (KROS) Reports Q2 Loss, Beats Revenue Estimates
- Y-mAbs Therapeutics: Deal Showcases Value And Challenges Of Biotech M&A (YMAB)
- YmAbs Therapeutics (YMAB) Surges 103.3%: Is This an Indication of Further Gains?
- U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.14%
- Y-mAbs Therapeutics stock downgraded to Hold by Truist after SERB acquisition
- Nasdaq Down 50 Points; ISM Services PMI Declines In July - Ameresco (NYSE:AMRC), Agilon Health (NYSE:AGL)
- Y-mAbs stock soars after SERB Pharmaceuticals announces acquisition
- Dow Surges Over 100 Points; Pfizer Earnings Top Views - Agilon Health (NYSE:AGL), Ichor Holdings (NASDAQ:ICHR)
- YmAbs Therapeutics (YMAB) Upgraded to Buy: Here's What You Should Know
- Y-mAbs Therapeutics announces results of annual shareholder meeting votes
- Clear Street raises YMAB stock target to $17, shares rise
- Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
- Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting
- H.C. Wainwright cuts YMAB stock target to $11, maintains Buy rating
- Y-mAbs Therapeutics: A Yawn From The Market Means Opportunity (YMAB)
- Y-mAbs Therapeutics, Inc. (YMAB) Q4 2024 Earnings Call Transcript
Frequently Asked Questions
What is YMAB stock price today?
Y-mAbs Therapeutics Inc stock is priced at 8.61 today. It trades within 8.59 - 8.61, yesterday's close was 8.59, and trading volume reached 830. The live price chart of YMAB shows these updates.
Does Y-mAbs Therapeutics Inc stock pay dividends?
Y-mAbs Therapeutics Inc is currently valued at 8.61. Dividend policy depends on the company, while investors also watch -34.97% and USD. View the chart live to track YMAB movements.
How to buy YMAB stock?
You can buy Y-mAbs Therapeutics Inc shares at the current price of 8.61. Orders are usually placed near 8.61 or 8.91, while 830 and 0.23% show market activity. Follow YMAB updates on the live chart today.
How to invest into YMAB stock?
Investing in Y-mAbs Therapeutics Inc involves considering the yearly range 3.55 - 16.11 and current price 8.61. Many compare 0.70% and 95.68% before placing orders at 8.61 or 8.91. Explore the YMAB price chart live with daily changes.
What are Y-mAbs Therapeutics Inc stock highest prices?
The highest price of Y-mAbs Therapeutics Inc in the past year was 16.11. Within 3.55 - 16.11, the stock fluctuated notably, and comparing with 8.59 helps spot resistance levels. Track Y-mAbs Therapeutics Inc performance using the live chart.
What are Y-mAbs Therapeutics Inc stock lowest prices?
The lowest price of Y-mAbs Therapeutics Inc (YMAB) over the year was 3.55. Comparing it with the current 8.61 and 3.55 - 16.11 shows potential long-term entry points. Watch YMAB moves on the chart live for more details.
When did YMAB stock split?
Y-mAbs Therapeutics Inc has gone through stock splits historically. These changes are visible in , 8.59, and -34.97% after corporate actions.
- Previous Close
- 8.59
- Open
- 8.59
- Bid
- 8.61
- Ask
- 8.91
- Low
- 8.59
- High
- 8.61
- Volume
- 830
- Daily Change
- 0.23%
- Month Change
- 0.70%
- 6 Months Change
- 95.68%
- Year Change
- -34.97%
- Act
- Fcst
- Prev